Free Trial
OTCMKTS:HALB

Halberd (HALB) Stock Price, News & Analysis

Halberd logo
$0.0039 0.00 (0.00%)
(As of 11/29/2024 ET)

About Halberd Stock (OTCMKTS:HALB)

Key Stats

Today's Range
$0.0029
$0.0040
50-Day Range
N/A
52-Week Range
$0.0024
$0.0121
Volume
12,959 shs
Average Volume
1.12 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Halberd Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
20th Percentile Overall Score

HALB MarketRank™: 

Halberd scored higher than 20% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Halberd.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Halberd is -0.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Halberd is -0.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Halberd has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Halberd has recently decreased by 44.08%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Halberd does not currently pay a dividend.

  • Dividend Growth

    Halberd does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Halberd has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Halberd has recently decreased by 44.08%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Halberd has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.81 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Halberd this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    1 people have added Halberd to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Halberd insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    75.60% of the stock of Halberd is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Halberd's insider trading history.
Receive HALB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Halberd and its competitors with MarketBeat's FREE daily newsletter.

HALB Stock News Headlines

How To Build An Echo Knight In DND
Best Weapons To Dual Wield In Elden Ring
Top investors are backing this “unlisted” stock
When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying attention. That’s why top firms like SoftBank and Maveron have already backed their latest venture, a company that’s transforming the $1.3 trillion vacation home market.
Best Martial Melee Weapons In DND, Ranked
See More Headlines

HALB Stock Analysis - Frequently Asked Questions

Halberd's stock was trading at $0.0049 at the beginning of the year. Since then, HALB shares have decreased by 20.4% and is now trading at $0.0039.
View the best growth stocks for 2024 here
.

Shares of HALB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Halberd investors own include Healthier Choices Management (HCMC), DatChat (DATS), BrewBilt Manufacturing (BBRW), Altamira Therapeutics (CYTO), Enzolytics (ENZC), Canoo (GOEV) and Jiuzi (JZXN).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Healthcare
Current Symbol
OTCMKTS:HALB
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (OTCMKTS:HALB) was last updated on 11/29/2024 by MarketBeat.com Staff
From Our Partners